glp 1 antagonist mechanism of action GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists in the

Pract Radiat Oncol 12(5):437-445, 2022

The mechanism is similar in principle: a solution is injected into the subcutaneous fat layer, and the active ingredients are believed to disrupt the membrane of fat cells so the triglyceride contents can be cleared by the lymphatic system over the following weeks

The insurers challenge is balancing innovation vs

Published evidence comparing drug costs to outcome measures for health insurers/systems remains sparse, but one study compared the treatment of type 2 diabetes with insulin versus treatment with GLP-1s and found that the higher drug and outpatient costs associated with GLP-1 treatment were offset by a reduction in healthcare costs from emergency visits and inpatient admissions